<DOC>
	<DOCNO>NCT00935129</DOCNO>
	<brief_summary>Randomized , two arm , open study order evaluate treatment satisfaction use OmniPod system compare conventional insulin pump adult type 1 diabetes . The study include two consecutive 12 week treatment period . According randomization , patient treat consecutively treatment arm : 12 week OmniPod system 12 week patient 's previous insulin pump vice versa .</brief_summary>
	<brief_title>Treatment Satisfaction Using OmniPod System Compared With Conventional Insulin Pump Adults With Type 1 Diabetes</brief_title>
	<detailed_description>A Randomized , two arm , open , crossover study order evaluate treatment satisfaction use OmniPod system compare conventional insulin pump adult type 1 diabetes . The study include two consecutive 12 week treatment period . According randomization , patient treat consecutively treatment arm : 12 week OmniPod system 12 week patient 's previous insulin pump vice versa . Study consist 4 clinic visit take place -2,0,12 24 week additional 4 telephone visit take place 4,8,16 20 week . In addition , patient invite one week prior visit 5 visit 8 order insert continuous glucose sensor . Patients complete DTSQ Comfort &amp; Function questionnaires week 0 , 12 24 , end study arm . On clinical visit follow parameter evaluate : vital sign , HbA1c , 4 7 point glucose profile , hypoglycemia event , hyperglycemia event pump related technical problem . The telephone visit include pump related technical problem solve AE/SAE reporting .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>1 . Type 1 diabetes diagnose least 1 year prior study entry 2 . Use continuous subcutaneous insulin infusion therapy least one year 3 . Age : 1835 year old 4 . HbA1c &gt; 8.0 5 . At least 4 self blood glucose measurement per day 6 . No one severe hypoglycaemic ketoacidosis episode within past year none within past month 7 . Capable read pump screen English 8 . Able understand sign subject inform consent form 1 . Any significant disease condition , include psychiatric disorder opinion principal investigator likely effect subject compliance subject ability complete study . 2 . Patients participate device drug study 3 . Clinical diagnosis hypoglycaemic unawareness 4 . Known dermal hypersensitivity product contain medical adhesive 5 . Taking prescription medication could complicate management glycemic control . 6 . Inability understand/complete Treatment satisfaction questionnaire</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Treatment satisfaction</keyword>
	<keyword>OmniPod</keyword>
	<keyword>Insulin pump</keyword>
	<keyword>diabetes</keyword>
</DOC>